Xolair is an injectable medicine indicated for adults and children with moderate to severe persistent allergic asthma, whose symptoms are not controlled with inhaled corticosteroids.
The active principle of this remedy is omalizumab, a substance that lowers the levels of free IgE antibody in the body, responsible for triggering the allergic cascade, thus reducing the incidence of asthma exacerbations.
What is it for
Xolair is indicated for adults and children over 6 years old with persistent, moderate to severe allergic asthma that cannot be controlled with inhaled corticosteroids.
Learn how to identify asthma symptoms in babies, children and adults.
How to use
The dose of Xolair and the frequency to be administered should be determined by the doctor, depending on the baseline serum level of immunoglobulin E, which must be measured before starting treatment, depending on body weight.
Who should not use
Xolair is contraindicated in cases of hypersensitivity to the active principle or any of the components of the formula and in children under 6 years of age.
In addition, this medication should not be used in pregnant or lactating women without medical advice.
Possible side effects
Some of the side effects that can occur during treatment with Xolair are headache, pain in the upper abdomen and reactions at the injection site, such as pain, erythema, itching and swelling.
In addition, although it is more rare, pharyngitis, vertigo, drowsiness, paresthesia, fainting, postural hypotension, flushing, cough allergic bronchospasm, nausea, diarrhea, poor digestion, hives, photosensitivity, weight gain, fatigue, swelling in the arms may still occur and flu symptoms.
Watch the following video and learn how food can help reduce asthma attacks: